Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States
- PMID: 30296434
- PMCID: PMC6309494
- DOI: 10.1053/j.gastro.2018.09.054
Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States
Abstract
Background & aims: Previous studies reported an association of the bacteria Helicobacter pylori, the primary cause of gastric cancer, and risk of colorectal cancer (CRC). However, these findings have been inconsistent, appear to vary with population characteristics, and may be specific for virulence factor VacA. To more thoroughly evaluate the potential association of H pylori antibodies with CRC risk, we assembled a large consortium of cohorts representing diverse populations in the United States.
Methods: We used H pylori multiplex serologic assays to analyze serum samples from 4063 incident cases of CRC, collected before diagnosis, and 4063 matched individuals without CRC (controls) from 10 prospective cohorts for antibody responses to 13 H pylori proteins, including virulence factors VacA and CagA. The association of seropositivity to H pylori proteins, as well as protein-specific antibody level, with odds of CRC was determined by conditional logistic regression.
Results: Overall, 40% of controls and 41% of cases were H pylori-seropositive (odds ratio [OR], 1.09; 95% CI, 0.99-1.20). H pylori VacA-specific seropositivity was associated with an 11% increased odds of CRC (OR, 1.11; 95% CI, 1.01-1.22), and this association was particularly strong among African Americans (OR, 1.45; 95% CI, 1.08-1.95). Additionally, odds of CRC increased with level of VacA antibody in the overall cohort (P = .008) and specifically among African Americans (P = .007).
Conclusions: In an analysis of a large consortium of cohorts representing diverse populations, we found serologic responses to H pylori VacA to associate with increased risk of CRC risk, particularly for African Americans. Future studies should seek to understand whether this marker is related to virulent H pylori strains carried in these populations.
Keywords: Cohort Studies; Epidemiology; Gastrointestinal Cancers.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Colon Cancer Risk and VacA Toxin of Helicobacter pylori.Gastroenterology. 2019 Jun;156(8):2356. doi: 10.1053/j.gastro.2018.11.083. Epub 2019 Mar 14. Gastroenterology. 2019. PMID: 30880020 No abstract available.
-
Reply.Gastroenterology. 2019 Jun;156(8):2356. doi: 10.1053/j.gastro.2019.04.040. Epub 2019 Apr 27. Gastroenterology. 2019. PMID: 31039340 No abstract available.
References
-
- Plummer M, de Martel C, Vignat J, et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 2016;4:e609–16. - PubMed
-
- Hooi JKY, Lai WY, Ng WK, et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology 2017;153:420–429. - PubMed
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7–30. - PubMed
-
- de Korwin JD, Ianiro G, Gibiino G, et al. Helicobacter pylori infection and extragastric diseases in 2017. Helicobacter 2017;22 Suppl 1. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- UM1 CA164973/CA/NCI NIH HHS/United States
- P30 CA016087/CA/NCI NIH HHS/United States
- R01 CA190428/CA/NCI NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- I01 BX000627/BX/BLRD VA/United States
- R01 AI118932/AI/NIAID NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- R01 CA040360/CA/NCI NIH HHS/United States
- R01 CA077955/CA/NCI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- R01 HL034595/HL/NHLBI NIH HHS/United States
- P30 DK058404/DK/NIDDK NIH HHS/United States
- R01 CA092447/CA/NCI NIH HHS/United States
- U01 CA167552/CA/NCI NIH HHS/United States
- UM1 CA182934/CA/NCI NIH HHS/United States
- P01 CA116087/CA/NCI NIH HHS/United States
- T32 CA057726/CA/NCI NIH HHS/United States
- K99 CA215314/CA/NCI NIH HHS/United States
- R00 CA215314/CA/NCI NIH HHS/United States
- R01 AI039657/AI/NIAID NIH HHS/United States
- R01 DK058587/DK/NIDDK NIH HHS/United States
- U01 CA202979/CA/NCI NIH HHS/United States
- R01 CA097193/CA/NCI NIH HHS/United States
- U01 CA164973/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
